<?xml version="1.0" encoding="UTF-8"?>
<oaidc:dc xmlns:oaidc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:coverage xsi:type="unistra:Coverage">FR</dc:coverage>
<dc:creator xsi:type="unistra:Auteur">Askri, Yecine</dc:creator>
<dc:date xsi:type="unistra:Date">2023-07-12</dc:date>
<dc:description xsi:type="unistra:Discipline" xml:langue="fre">Pharmacie</dc:description>
<dc:description xsi:type="unistra:Resume" xml:langue="fre">Cette thèse est le fruit d’un stage hospitalier de 5ème année au service de virologie durant lequel une analyse de caractéristiques et performances des tests antigéniques disponibles sur le marché a été réalisée. Ce travail a permis de déterminer quelle place occupaient ces derniers dans la gestion de la pandémie.Une descripition du virus a également été effectuée.</dc:description>
<dc:description xsi:type="unistra:Resume" xml:langue="fre">This thesis is the result of a 5th year hospital internship in the virology department during which an analysis of the characteristics and performance of the antigenic tests available on the market was carried out. This work made it possible to determine which place these tests occupied in the management of the pandemic. A description of the virus was also carried out.</dc:description>
<dc:format xsi:type="dcterms:IMT">PDF</dc:format>
<dc:rights xsi:type="unistra:Droits">Accès réservé aux membres de l'Université de Strasbourg sur authentification</dc:rights>
<dc:identifier xsi:type="dcterms:URI">https://publication-theses.unistra.fr/restreint/theses_exercice/PHA/2023/2023_ASKRI_Yecine.pdf</dc:identifier>
<dc:language xsi:type="dcterms:ISO639-2">fr</dc:language>
<dc:publisher xsi:type="unistra:Composante">Faculté de pharmacie</dc:publisher>
<dc:source xsi:type="dcterms:URI">http://www.sudoc.fr/27198239X</dc:source>
<dc:subject xml:langue="fre">SARS-CoV-2 (virus) Dépistage</dc:subject>
<dc:subject xml:langue="fre">Tests de diagnostic rapide</dc:subject>
<dc:subject xml:langue="fre">SARS-CoV-2</dc:subject>
<dc:subject xml:langue="fre">Antigénique</dc:subject>
<dc:subject xml:langue="fre">Test</dc:subject>
<dc:subject xml:langue="fre">Pandémie</dc:subject>
<dc:subject xml:langue="fre">COVID-19</dc:subject>
<dc:subject xml:langue="fre">Virologie</dc:subject>
<dc:subject xml:langue="fre">Sensibilité</dc:subject>
<dc:subject xml:langue="fre">Spécificité</dc:subject>
<dc:subject xml:langue="fre">SARS-CoV-2</dc:subject>
<dc:subject xml:langue="fre">Antigen</dc:subject>
<dc:subject xml:langue="fre">Test</dc:subject>
<dc:subject xml:langue="fre">Pandemic</dc:subject>
<dc:subject xml:langue="fre">COVID-19</dc:subject>
<dc:subject xml:langue="fre">Virology</dc:subject>
<dc:subject xml:langue="fre">Sensitivity</dc:subject>
<dc:subject xml:langue="fre">Specificity</dc:subject>
<dc:subject xml:langue="fre">615</dc:subject>
<dc:title xsi:type="unistra:Titre" xml:lang="fre">SARS-CoV-2 et diagnostic par les tests antigéniques:état des lieux de la situation entre février 2021 et mars 2021</dc:title>
<dc:type xsi:type="unistra:Mention">Thèse d'exercice</dc:type>
<dc:contributor xsi:type="unistra:Directeur">Emmanuel Boutant</dc:contributor>
<dc:type xsi:type="unistra:TheseExercice">These d'exercice Unistra</dc:type>
</oaidc:dc>
